DalsnaFinance

Aignostics Partners with the Pancreatic Cancer Action Network to Advance Pancreatic Cancer Research

Markets PR Newswire By PR Newswire 09 Jun 2026 10:00 1 min read
Aignostics Partners with the Pancreatic Cancer Action Network to Advance Pancreatic Cancer Research

Collaboration will apply Aignostics' AI-technology to PanCAN's multimodal pancreatic cancer dataset, with results made broadly accessible to both academic and life sciences researchers. LOS ANGELES and BERLIN and NEW YORK, June 9, 2026 /PRNewswire/ -- Today, Aignostics announced a new...

Collaboration will apply Aignostics' AI-technology to PanCAN's multimodal pancreatic cancer dataset, with results made broadly accessible to both academic and life sciences researchers. LOS ANGELES and BERLIN and NEW YORK, June 9, 2026 /PRNewswire/ -- Today, Aignostics announced a new...

Read the full story on PR Newswire → Opens the original article on www.prnewswire.com

Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.